Total Payments
$699.86
2024 Payments
$307.70
Companies
12
Transactions
36
Medicare Patients
487
Medicare Billing
$70,765
Payment Breakdown by Category
Food & Beverage$692.03 (98.9%)
Education$7.83 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $692.03 | 35 | 98.9% |
| Education | $7.83 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $158.57 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $112.13 | 8 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $89.15 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $86.95 | 5 | $0 (2024) |
| UCB, Inc. | $65.93 | 2 | $0 (2024) |
| ITI, Inc. | $56.26 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.67 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $28.52 | 2 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $27.87 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $17.10 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $307.70 | 10 | Neurocrine Biosciences, Inc. ($158.57) |
| 2023 | $115.80 | 8 | Teva Pharmaceuticals USA, Inc. ($55.59) |
| 2022 | $164.23 | 10 | ITI, Inc. ($56.26) |
| 2021 | $112.13 | 8 | Sunovion Pharmaceuticals Inc. ($112.13) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $47.82 | General |
| Category: Neurology | ||||||
| 05/31/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neurology | ||||||
| 05/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PSYCHIATRY | ||||||
| 05/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Neuropsychiatry | ||||||
| 03/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Neuropsychiatry | ||||||
| 03/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Gastroenterology | ||||||
| 12/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: CNS | ||||||
| 08/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Central Nervous System | ||||||
| 07/11/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Central Nervous System | ||||||
| 02/24/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: CNS | ||||||
| 01/19/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Central Nervous System | ||||||
| 09/27/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Central Nervous System | ||||||
| 09/20/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/31/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/10/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 188 | 271 | $29,066 | $22,857 |
| 2022 | 5 | 145 | 244 | $26,252 | $19,769 |
| 2021 | 4 | 62 | 115 | $15,685 | $10,941 |
| 2020 | 4 | 92 | 175 | $26,733 | $17,198 |
Total Patients
487
Total Services
805
Medicare Billing
$70,765
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 162 | $16,241 | $10,915 | 67.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $9,625 | $9,433 | 98.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 17 | $1,700 | $1,333 | 78.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 15 | $1,500 | $1,176 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 149 | $14,982 | $10,179 | 67.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $5,340 | $5,275 | 98.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 23 | $2,530 | $1,802 | 71.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $1,800 | $1,403 | 78.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $1,600 | $1,109 | 69.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 56 | $6,160 | $4,478 | 72.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $2,575 | $2,575 | 100.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 20 | $3,650 | $2,425 | 66.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 14 | 18 | $3,300 | $1,464 | 44.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 92 | $12,170 | $7,532 | 61.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 36 | $6,863 | $5,129 | 74.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $2,585 | $2,359 | 91.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 21 | 26 | $5,115 | $2,177 | 42.6% |
About Dr. John Preddy, DO
Dr. John Preddy, DO is a Rural Health healthcare provider based in Uvalde, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922064955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Preddy, DO has received a total of $699.86 in payments from pharmaceutical and medical device companies, with $307.70 received in 2024. These payments were reported across 36 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($692.03).
As a Medicare-enrolled provider, Preddy has provided services to 487 Medicare beneficiaries, totaling 805 services with total Medicare billing of $70,765. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Rural Health
- Other Specialties Family Medicine
- Location Uvalde, TX
- Active Since 04/26/2006
- Last Updated 01/25/2021
- Taxonomy Code 261QR1300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922064955
Products in Payments
- INGREZZA (Drug) $158.57
- LATUDA (Drug) $112.13
- REXULTI (Drug) $71.33
- Nayzilam (Drug) $65.93
- CAPLYTA (Drug) $56.26
- AUSTEDO (Drug) $50.63
- Austedo XR (Drug) $38.52
- XIFAXAN (Drug) $31.67
- ABILIFY MAINTENA (Drug) $29.44
- AIRSUPRA (Drug) $28.52
- NUPLAZID (Drug) $27.87
- LEQVIO (Drug) $17.10
- APTIOM (Drug) $11.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.